Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins
暂无分享,去创建一个
Lennart Martens | Marion Koopmans | Elien Vandermarliere | Jeroen Cremer | M. Koopmans | L. Martens | E. Vandermarliere | P. Rota | G. Leroux-Roels | R. V. Van BInnendijk | V. Hutse | S. Gouma | Paul A. Rota | Sigrid Gouma | Tessa Vermeire | Steven Van Gucht | Veronik Hutse | Geert Leroux-Roels | Rob van Binnendijk | S. Van Gucht | J. Cremer | T. Vermeire | R. van Binnendijk
[1] S. Rubin,et al. Recent Mumps Outbreaks in Vaccinated Populations: No Evidence of Immune Escape , 2011, Journal of Virology.
[2] Shuigeng Zhou,et al. Prediction of protein-protein interaction sites using an ensemble method , 2009, BMC Bioinformatics.
[3] M. Dilcher,et al. Monitoring Viral Genetic Variation as a Tool To Improve Molecular Diagnostics for Mumps Virus , 2018, Journal of Clinical Microbiology.
[4] W. Donovan,et al. An outbreak of mumps with genetic strain variation in a highly vaccinated student population in Scotland , 2017, Epidemiology and Infection.
[5] M. Šantak,et al. Identification of conformational neutralization sites on the fusion protein of mumps virus. , 2015, The Journal of general virology.
[6] M. May,et al. Emergent lineages of mumps virus suggest the need for a polyvalent vaccine. , 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[7] R. Bremel,et al. Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes? , 2013, Human vaccines & immunotherapeutics.
[8] Jing Ren,et al. Tertiary structure-based prediction of conformational B-cell epitopes through B factors , 2014, Bioinform..
[9] W. Kabsch,et al. Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.
[10] R. Lamb,et al. Fusion Activation through Attachment Protein Stalk Domains Indicates a Conserved Core Mechanism of Paramyxovirus Entry into Cells , 2014, Journal of Virology.
[11] Robert C. Edgar,et al. MUSCLE: a multiple sequence alignment method with reduced time and space complexity , 2004, BMC Bioinformatics.
[12] M. Roelants,et al. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? , 2004, Vaccine.
[13] M. James,et al. Calcium-binding sites in proteins: a structural perspective. , 1991, Advances in protein chemistry.
[14] E. Norrby,et al. Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. , 1990, Virus research.
[15] P. Minor,et al. Mumps vaccines and meningitis , 1992, The Lancet.
[16] S. Vaidya,et al. Complete genome sequence of mumps viruses isolated from patients with parotitis, pancreatitis and encephalitis in India. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[17] K. Yamanishi,et al. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps virus Urabe vaccine strain. , 1997, Journal of Infectious Diseases.
[18] H. D. de Melker,et al. Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection. , 2016, Vaccine.
[19] Teresa Blasco Máñez. a structural perspective, , 2011 .
[20] K. Wright,et al. Genetic studies on a mumps vaccine strain associated with meningitis , 1998, Reviews in medical virology.
[21] S. Plotkin. Mumps: A Pain in the Neck. , 2018, Journal of the Pediatric Infectious Diseases Society.
[22] N. Yoshida,et al. Leucine at Position 383 of Fusion Protein Is Responsible for Fusogenicity of Wild-Type Mumps Virus in B95a Cells , 2010, Intervirology.
[23] B. He,et al. Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China. , 2017, Vaccine.
[24] R. Myers,et al. Genomic diversity of mumps virus and global distribution of the 12 genotypes , 2015, Reviews in medical virology.
[25] M. Koopmans,et al. Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009-2012). , 2014, The Journal of general virology.
[26] C. Russell,et al. The structural basis of paramyxovirus invasion , 2006, Trends in Microbiology.
[27] 洋一 中西,et al. 2012: , 2012, Disasters and Social Reproduction.
[28] M. Šantak,et al. Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies , 2012, Epidemiology and Infection.
[29] W. Bellini,et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. , 2008, The Journal of infectious diseases.
[30] D. Lackman,et al. Observations on a mumps epidemic in a virgin population. , 1960, American journal of hygiene.
[31] K. Dimock,et al. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. , 1996, The Journal of infectious diseases.
[32] Vincent B. Chen,et al. Correspondence e-mail: , 2000 .
[33] R. Lamb,et al. Structure of the Newcastle disease virus F protein in the post-fusion conformation. , 2010, Virology.
[34] C. Orvell,et al. Characterization of genotype-specific epitopes of the HN protein of mumps virus. , 1997, The Journal of general virology.
[35] Deepti D Deobagkar,et al. Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. , 2007, Virology.
[36] Gert Vriend,et al. Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field , 2002, Proteins.
[37] N. Abramson,et al. Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases , 2015, Human vaccines & immunotherapeutics.
[38] Ilkka Julkunen,et al. Minor Changes in the Hemagglutinin of Influenza A(H1N1)2009 Virus Alter Its Antigenic Properties , 2011, PloS one.
[39] Umesh Parashar,et al. Recent resurgence of mumps in the United States. , 2008, The New England journal of medicine.
[40] R. Lamb,et al. Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein , 2012, Proceedings of the National Academy of Sciences.
[41] V. Hutse,et al. Mumps increase in Flanders, Belgium, 2012-2013: results from temporary mandatory notification and a cohort study among university students. , 2014, Vaccine.
[42] S. Rubin,et al. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] W. Bellini,et al. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. , 2011, The Journal of infectious diseases.
[44] L. Martens,et al. Scop3D: Three‐dimensional visualization of sequence conservation , 2015, Proteomics.
[45] C. Chothia. The nature of the accessible and buried surfaces in proteins. , 1976, Journal of molecular biology.
[46] J. Sohn,et al. Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. , 2007, Vaccine.
[47] Robert C. Edgar,et al. MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.
[48] D. Lackman,et al. Observations on a mumps epidemic in a "virgin" population. 1958. , 1959, American journal of epidemiology.
[49] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[50] S. Rubin,et al. Functional consequences of attenuating mutations in the haemagglutinin neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain. , 2007, The Journal of general virology.
[51] Pinak Chakrabarti,et al. Quantifying the accessible surface area of protein residues in their local environment. , 2002, Protein engineering.
[52] François Stricher,et al. The FoldX web server: an online force field , 2005, Nucleic Acids Res..
[53] W. P. Duprex,et al. Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2 , 2009, The Journal of general virology.
[54] A. Heath,et al. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. , 1993, The Journal of general virology.
[55] I. Longden,et al. EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.
[56] I. Herrera-Camacho,et al. Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein. , 2009, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[57] M. Koopmans,et al. Mumps virus F gene and HN gene sequencing as a molecular tool to study mumps virus transmission. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[58] S. Fischer,et al. Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein. , 2001, Virus research.
[59] B. Haughey,et al. A pain in the neck , 2014, The Laryngoscope.
[60] H. D. de Melker,et al. Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012 , 2014, Emerging infectious diseases.
[61] Luis E. Lowe,et al. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults , 2006, Canadian Medical Association Journal.
[62] P. Yates,et al. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. , 1998, The Journal of infectious diseases.
[63] Y. Grad,et al. Vaccine waning and mumps re-emergence in the United States , 2017, Science Translational Medicine.
[64] R. Lamb,et al. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. , 2005, Structure.
[65] P E Bourne,et al. The Protein Data Bank. , 2002, Nucleic acids research.
[66] A. Yamada,et al. Effect on fusion induction of point mutations introduced into the F protein of mumps virus. , 1994, Virology.
[67] N. Bayley,et al. Failure , 1890, The Hospital.
[68] M. Paunio,et al. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. , 2012, The Journal of infectious diseases.
[69] E. Norrby,et al. The mumps virus fusion protein mRNA sequence and homology among the paramyxoviridae proteins. , 1989, The Journal of general virology.
[70] Gert Vriend,et al. A series of PDB related databases for everyday needs , 2010, Nucleic Acids Res..
[71] D. Kohda,et al. Trisaccharide containing α2,3-linked sialic acid is a receptor for mumps virus , 2016, Proceedings of the National Academy of Sciences of the United States of America.